Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP1295505.RACG0Fa2ejRcp4DLkUKq4T7e9chSavHrFwXJy7_UiAvRw130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP1295505.RACG0Fa2ejRcp4DLkUKq4T7e9chSavHrFwXJy7_UiAvRw130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP1295505.RACG0Fa2ejRcp4DLkUKq4T7e9chSavHrFwXJy7_UiAvRw130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP1295505.RACG0Fa2ejRcp4DLkUKq4T7e9chSavHrFwXJy7_UiAvRw130_provenance.
- NP1295505.RACG0Fa2ejRcp4DLkUKq4T7e9chSavHrFwXJy7_UiAvRw130_assertion description "[Specific inhibitors against BCR-ABL, such as Imatinib mesylate (IM), have greatly improved CML management; however, no single agent is a cure yet.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1295505.RACG0Fa2ejRcp4DLkUKq4T7e9chSavHrFwXJy7_UiAvRw130_provenance.
- NP1295505.RACG0Fa2ejRcp4DLkUKq4T7e9chSavHrFwXJy7_UiAvRw130_assertion evidence source_evidence_literature NP1295505.RACG0Fa2ejRcp4DLkUKq4T7e9chSavHrFwXJy7_UiAvRw130_provenance.
- NP1295505.RACG0Fa2ejRcp4DLkUKq4T7e9chSavHrFwXJy7_UiAvRw130_assertion SIO_000772 26554155 NP1295505.RACG0Fa2ejRcp4DLkUKq4T7e9chSavHrFwXJy7_UiAvRw130_provenance.
- NP1295505.RACG0Fa2ejRcp4DLkUKq4T7e9chSavHrFwXJy7_UiAvRw130_assertion wasDerivedFrom befree-2016 NP1295505.RACG0Fa2ejRcp4DLkUKq4T7e9chSavHrFwXJy7_UiAvRw130_provenance.
- NP1295505.RACG0Fa2ejRcp4DLkUKq4T7e9chSavHrFwXJy7_UiAvRw130_assertion wasGeneratedBy ECO_0000203 NP1295505.RACG0Fa2ejRcp4DLkUKq4T7e9chSavHrFwXJy7_UiAvRw130_provenance.
- befree-2016 importedOn "2016-02-19" NP1295505.RACG0Fa2ejRcp4DLkUKq4T7e9chSavHrFwXJy7_UiAvRw130_provenance.